GB0900563D0 - New combination - Google Patents

New combination

Info

Publication number
GB0900563D0
GB0900563D0 GB0900563A GB0900563A GB0900563D0 GB 0900563 D0 GB0900563 D0 GB 0900563D0 GB 0900563 A GB0900563 A GB 0900563A GB 0900563 A GB0900563 A GB 0900563A GB 0900563 D0 GB0900563 D0 GB 0900563D0
Authority
GB
United Kingdom
Prior art keywords
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0900563A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
AstraZeneca AB
Original Assignee
Argenta Discovery Ltd
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd, AstraZeneca AB filed Critical Argenta Discovery Ltd
Priority to GB0900563A priority Critical patent/GB0900563D0/en
Publication of GB0900563D0 publication Critical patent/GB0900563D0/en
Priority to AU2009247021A priority patent/AU2009247021B2/en
Priority to RU2010147881/15A priority patent/RU2010147881A/en
Priority to CN2012104520326A priority patent/CN102908624A/en
Priority to MX2010012019A priority patent/MX2010012019A/en
Priority to PCT/SE2009/050525 priority patent/WO2009139708A1/en
Priority to CA2723909A priority patent/CA2723909A1/en
Priority to CN200980127403XA priority patent/CN102088976B/en
Priority to KR1020107025392A priority patent/KR20110010725A/en
Priority to EP09746868.0A priority patent/EP2315589A4/en
Priority to BRPI0912657A priority patent/BRPI0912657A2/en
Priority to JP2011509442A priority patent/JP2011520877A/en
Priority to US12/992,226 priority patent/US20110190309A1/en
Ceased legal-status Critical Current

Links

GB0900563A 2008-05-13 2009-01-14 New combination Ceased GB0900563D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0900563A GB0900563D0 (en) 2009-01-14 2009-01-14 New combination
US12/992,226 US20110190309A1 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST
CA2723909A CA2723909A1 (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
RU2010147881/15A RU2010147881A (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT CONTAINING A MUSCARIN RECEPTOR ANTAGONIST AND β2-ADRENOREPTECT AGONIST
CN2012104520326A CN102908624A (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
MX2010012019A MX2010012019A (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a î²2-adrenoceptor agonist.
PCT/SE2009/050525 WO2009139708A1 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
AU2009247021A AU2009247021B2 (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
CN200980127403XA CN102088976B (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
KR1020107025392A KR20110010725A (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
EP09746868.0A EP2315589A4 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST
BRPI0912657A BRPI0912657A2 (en) 2008-05-13 2009-05-12 pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoreceptor agonist
JP2011509442A JP2011520877A (en) 2008-05-13 2009-05-12 Medicament containing muscarinic receptor antagonist and β2-adrenergic receptor agonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0900563A GB0900563D0 (en) 2009-01-14 2009-01-14 New combination

Publications (1)

Publication Number Publication Date
GB0900563D0 true GB0900563D0 (en) 2009-02-11

Family

ID=40379546

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0900563A Ceased GB0900563D0 (en) 2008-05-13 2009-01-14 New combination

Country Status (1)

Country Link
GB (1) GB0900563D0 (en)

Similar Documents

Publication Publication Date Title
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
ZA201202612B (en) Combination
EP2462514A4 (en) Greenbooks
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
IL219103A0 (en) Combination
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
IL219786A0 (en) Combination
ZA201202494B (en) Combination
ZA201202173B (en) Combination
ZA201202495B (en) Combination
ZA201202258B (en) Combination
IL218801A0 (en) Combination
EP2510125A4 (en) Hyperprimers
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4926P (en) Bonscalib Scaevola aemula
GB0900563D0 (en) New combination
GB0906696D0 (en) Combination
GB0901391D0 (en) Combination
EG26256A (en) Oxyga
AU329913S (en) Cupcan
AU324442S (en) Keylight

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)